| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,650 | $90 | $144.9K |
| 55866 | The provider removes the prostate gland through a minimally invasive laparoscopic approach behind the pubic bone. The surgery is radical, meaning the entire prostate is removed, often to treat… | 90 | $930 | $79.6K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 430 | $170 | $73.3K |
| 52224 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 120 | $580 | $71.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 460 | $130 | $61.6K |
| J9155 | Injection, degarelix, 1 mg | 19,920 | $1 | $59.8K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 9,500 | $10 | $47.5K |
| J0897 | Injection, denosumab, 1 mg | 2,340 | $20 | $42.1K |
| 53854 | The provider uses a radiofrequency–generated water vapor thermal device to destroy prostate tissue to treat BPH and lower urinary tract symptoms. | 30 | $1,270 | $33K |
| J3490 | Unclassified drugs | 40 | $740 | $31.9K |